| Model Number |
PED2-425-25 |
| Medical Device Problem Code |
Activation Failure (3270)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/10/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received a report that the pipeline failed to open distally.The patient was undergoing treatment for an unruptured, saccular aneurysm located in the right ica.The max diameter was 14mm, and the neck diameter was 8mm.The patient's vessel tortuosity was severe.The landing zone was 3.12mm distal and 4.16mm proximal. dual antiplatelet treatment was administered, and the pru level was 80.It was reported that while attempting to deploy the pipeline, the distal end had the "flower effect." the doctor recaptured it and tried again and was able to get the distal end to open with the wire/catheter.The device was placed successfully, but with much manipulation to get it to open.The pipeline was not positioned in a bend, and less than 50% had been deployed when it failed to open.The pipeline had been resheathed 2 or less times.Full wall apposition was achieved, and angiographic results post procedure were said to be great. the patient did not experience any injury or complications.The devices were prepared according to the instructions for use (ifu).
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|